You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 23, 2024

TAPINAROF - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for tapinarof and what is the scope of freedom to operate?

Tapinarof is the generic ingredient in one branded drug marketed by Dermavant Sci and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tapinarof has sixty-nine patent family members in thirty-six countries.

One supplier is listed for this compound.

Summary for TAPINAROF
International Patents:69
US Patents:9
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 60
Clinical Trials: 11
Patent Applications: 211
What excipients (inactive ingredients) are in TAPINAROF?TAPINAROF excipients list
DailyMed Link:TAPINAROF at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TAPINAROF
Generic Entry Date for TAPINAROF*:
Constraining patent/regulatory exclusivity:
Dosage:
CREAM;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for TAPINAROF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dermavant Sciences, Inc.Phase 4
Dermavant Sciences, Inc.Phase 2
Dermavant Sciences, Inc.Phase 3

See all TAPINAROF clinical trials

Pharmacology for TAPINAROF

US Patents and Regulatory Information for TAPINAROF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TAPINAROF

Country Patent Number Title Estimated Expiration
Australia 2023274224 PROCESS FOR PREPARING TAPINAROF ⤷  Sign Up
Israel 282304 תכשירים רוקחיים לשימוש מקומי (Topical pharmaceutical compositions) ⤷  Sign Up
Eurasian Patent Organization 201792559 ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ ⤷  Sign Up
Denmark 3297605 ⤷  Sign Up
European Patent Office 4094752 COMPOSITIONS PHARMACEUTIQUES TOPIQUES (TOPICAL PHARMACEUTICAL COMPOSITIONS) ⤷  Sign Up
Brazil 112020009158 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.